Autologous Natural Killer T Cells Infusion for the Treatment of Cancer

Summary

The purpose of this study is to assess the safety and effectiveness of natural killer T (NKT) cell-based autologous adoptive immunotherapy in subjects with metastatic, treatment-refractory breast cancer, glioma, hepatocellular carcinoma, squamous cell lung cancer, pancreatic cancer, colon cancer or prostate cancer.

Timeline

Start

2013-01

Primary completion

2016-05

Completion

2017-06

Drugs

Indications